In addition, the functional role of the MEK5-ERK5 axis in GSCs stemness regulation and tumorigenesis remains unknown in vitro and in vivo, regardless of previous reports showing that ERK5 inhibition in differentiated glioma cells decreases tumor cell growth and reduces drug resistance (22). This evidence concerns the gene MAP2K5 and glioma.